Clinical Trial Update: A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 1]

View source ↗

Summary

This clinical trial update reports completion of a Phase 1b study of volociximab in combination with carboplatin and paclitaxel as first-line therapy for advanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Volociximab (volociximab)

Snippet

Sponsor: AbbVie | Conditions: Non-small Cell Lung Cancer | Phase 1 | Status: COMPLETED